What does DR. PIETER VAN DE GENDER do?

DR. PIETER VAN DE GENDER is a specialist medical practice in Beringen. Private Limited, started on 13 August 2009, 1 establishment.

What is the address of DR. PIETER VAN DE GENDER?

The registered office of DR. PIETER VAN DE GENDER is located at Stalse Molenstraat 20, 3582 Beringen.

Is DR. PIETER VAN DE GENDER still active?

Yes. According to the CBE (29 September 2026) DR. PIETER VAN DE GENDER is active, legal situation “Normale toestand”, started on 13 August 2009.

Is DR. PIETER VAN DE GENDER registered on Peppol?

Yes, DR. PIETER VAN DE GENDER is registered on the Peppol network with ID 0208:0818383357.

What is the enterprise number of DR. PIETER VAN DE GENDER?

The enterprise number of DR. PIETER VAN DE GENDER is BE0818383357.

When was DR. PIETER VAN DE GENDER founded?

DR. PIETER VAN DE GENDER was founded on 13 August 2009.

Who are the directors of DR. PIETER VAN DE GENDER?

According to the 2025 annual accounts, the directors of DR. PIETER VAN DE GENDER are: Pieter Van De Gender.

Is DR. PIETER VAN DE GENDER a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 13 August 2009; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DR. PIETER VAN DE GENDER make in 2025?

DR. PIETER VAN DE GENDER posted a profit after taxes of € 217,538 in financial year 2025.

What is the revenue of DR. PIETER VAN DE GENDER?

As a small company, DR. PIETER VAN DE GENDER is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 329,224.

DR. PIETER VAN DE GENDER (Private Limited) - Beringen

Dossier DR. PIETER VAN DE GENDER, printed on 29 September 2026 from databakkes.be/en/0818383357/dr-pieter-van-de-gender. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DR. PIETER VAN DE GENDER from Beringen, company number BE0818383357, closed financial year 2025 with a result of € 217,538 after tax. For that financial year DR. PIETER VAN DE GENDER recorded a gross margin of € 329,224 and equity of € 1 million. Compared with financial year 2024, the result moved from € 243,925 to € 217,538. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.

What it is worth Healthy

€ 1 million

▼ 22% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 217,538

▼ 11% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 290,347

▼ 12% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 499,222 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 7,475

▲ 12% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 4 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 47,916

▼ 21% vs 2024

€ 12,500 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.

Owed to suppliers

€ 9,030

▲ € 8,082 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 27,051

▲ 63% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 255,048 Gross margin 2022: € 255,048 First fiscal year in the series	€ 306,827 Gross margin 2023: € 306,827 ▲ 20% vs 2022 (€ 255,048) Favourable step	€ 328,638 Gross margin 2024: € 328,638 ▲ 7% vs 2023 (€ 306,827) Favourable step	€ 329,224 Gross margin 2025: € 329,224 Unchanged (€ 328,638) Favourable step
Profit after taxes	€ 160,978 Profit after taxes 2022: € 160,978 First fiscal year in the series	€ 161,446 Profit after taxes 2023: € 161,446 Unchanged (€ 160,978) Favourable step	€ 243,925 Profit after taxes 2024: € 243,925 ▲ 51% vs 2023 (€ 161,446) Favourable step	€ 217,538 Profit after taxes 2025: € 217,538 ▼ 11% vs 2024 (€ 243,925) Unfavourable step	▼ 11%
Equity	€ 1,087,190 Equity 2022: € 1,087,190 First fiscal year in the series	€ 1,164,426 Equity 2023: € 1,164,426 ▲ 7% vs 2022 (€ 1,087,190) Favourable step	€ 1,287,824 Equity 2024: € 1,287,824 ▲ 11% vs 2023 (€ 1,164,426) Favourable step	€ 1,006,140 Equity 2025: € 1,006,140 ▼ 22% vs 2024 (€ 1,287,824) Unfavourable step	▼ 22%
Total debts	€ 123,033 Total debts 2022: € 123,033 First fiscal year in the series	€ 97,923 Total debts 2023: € 97,923 ▼ 20% vs 2022 (€ 123,033) Favourable step	€ 78,052 Total debts 2024: € 78,052 ▼ 20% vs 2023 (€ 97,923) Favourable step	€ 94,261 Total debts 2025: € 94,261 ▲ 21% vs 2024 (€ 78,052) Unfavourable step	▲ 21%
Cash	€ 542,881 Cash 2022: € 542,881 First fiscal year in the series	€ 652,333 Cash 2023: € 652,333 ▲ 20% vs 2022 (€ 542,881) Favourable step	€ 331,670 Cash 2024: € 331,670 ▼ 49% vs 2023 (€ 652,333) Unfavourable step	€ 290,347 Cash 2025: € 290,347 ▼ 12% vs 2024 (€ 331,670) Unfavourable step	▼ 12%
Land & buildings	€ 157,853 Land & buildings 2022: € 157,853 First fiscal year in the series	€ 153,422 Land & buildings 2023: € 153,422 ▼ 3% vs 2022 (€ 157,853) Unchanged	€ 148,992 Land & buildings 2024: € 148,992 ▼ 3% vs 2023 (€ 153,422) Unchanged	€ 144,561 Land & buildings 2025: € 144,561 ▼ 3% vs 2024 (€ 148,992) Unchanged	▼ 3%
Retained profit	€ 1,074,790 Retained profit 2022: € 1,074,790 First fiscal year in the series	€ 1,152,026 Retained profit 2023: € 1,152,026 ▲ 7% vs 2022 (€ 1,074,790) Favourable step	€ 1,275,424 Retained profit 2024: € 1,275,424 ▲ 11% vs 2023 (€ 1,152,026) Favourable step	€ 993,740 Retained profit 2025: € 993,740 ▼ 22% vs 2024 (€ 1,275,424) Unfavourable step	▼ 22%
Dividend	€ 210,526 Dividend 2022: € 210,526 First fiscal year in the series	€ 84,211 Dividend 2023: € 84,211 ▼ 60% vs 2022 (€ 210,526) Unchanged	€ 120,526 Dividend 2024: € 120,526 ▲ 43% vs 2023 (€ 84,211) Unchanged	€ 499,222 Dividend 2025: € 499,222 ▲ € 378,696 vs 2024 (€ 120,526) Unchanged	▲ € 378,696
Bank debt	€ 85,416 Bank debt 2022: € 85,416 First fiscal year in the series	€ 72,916 Bank debt 2023: € 72,916 ▼ 15% vs 2022 (€ 85,416) Favourable step	€ 60,416 Bank debt 2024: € 60,416 ▼ 17% vs 2023 (€ 72,916) Favourable step	€ 47,916 Bank debt 2025: € 47,916 ▼ 21% vs 2024 (€ 60,416) Favourable step	▼ 21%
Balance sheet total	€ 1,210,223 Balance sheet total 2022: € 1,210,223 First fiscal year in the series	€ 1,262,348 Balance sheet total 2023: € 1,262,348 ▲ 4% vs 2022 (€ 1,210,223) Unchanged	€ 1,365,876 Balance sheet total 2024: € 1,365,876 ▲ 8% vs 2023 (€ 1,262,348) Unchanged	€ 1,100,401 Balance sheet total 2025: € 1,100,401 ▼ 19% vs 2024 (€ 1,365,876) Unchanged	▼ 19%

Key figures of DR. PIETER VAN DE GENDER, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR. PIETER VAN DE GENDER?

What happened at DR. PIETER VAN DE GENDER in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 31, 2026 New annual accounts for financial year 2025: profit of € 217,538 (▼ 11% vs 2024). filed late Source: NBB ↗
2009 Pieter Van De Gender became a director. NBB
Aug 13, 2009 New establishment in Beringen. KBO
Aug 13, 2009 Start of the company according to the CBE. KBO

In short

From € 160,978 profit in 2022 to € 217,538 profit in 2025.

Paid € 354,216 in corporate taxes since 2022.

Best year ever: 2024, with € 243,925 profit.

Paid out € 914,485 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DR. PIETER VAN DE GENDER? We notify you, reason included.

Follow DR. PIETER VAN DE GENDER

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Pieter Van De Gender

DR. PIETER VAN DE GENDER

Behind DR. PIETER VAN DE GENDER is Pieter Van De Gender.

See the full network in the app

Directors

According to the 2025 annual accounts

Pieter Van De Gender

Director

since 2009

Establishments

Establishment units

Physical locations of this company

Registered office

Stalse Molenstraat 20

3582 Beringen

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0818.383.357
VAT number: BE 0818.383.357
Registered office: Stalse Molenstraat 20, 3582 Beringen
Names & denominations: DR. PIETER VAN DE GENDER
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 13 August 2009
Peppol: Active · Active since 14 Nov 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗